Beijing Biostar Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2563?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	3,592,932	0.985%
Institutions	21,827,261	5.99%
VC/PE Firms	29,426,685	8.07%
Employee Share Scheme	58,616,436	16.1%
Private Companies	100,199,668	27.5%
General Public	150,925,018	41.4%

Dilution of Shares: 2563 only recently listed within the past 12 months

Top Shareholders

Top 8 shareholders own 58.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	Beijing Biostar Pharmaceuticals Co., Ltd, ESOP	58,616,436	HK$1.9b	0%	no data
11.1%	Baygen QT Inc	40,505,885	HK$1.3b	0%	no data
9.54%	Tibet Xinsheng Deyuan Venture Capital Management Co., Ltd	34,798,296	HK$1.1b	0%	no data
8.07%	SDIC (Shanghai) Venture Capital Management Co., Ltd.	29,426,685	HK$963.7m	0%	5.22%
6.71%	Tibet Renhe Zhengtai Venture Capital Management Co., Ltd.	24,475,926	HK$801.6m	0%	no data
5.99%	Shenzhen Efung Investment Management Limited Partnership Enterprise	21,827,261	HK$714.8m	0%	no data
0.99%	Li Tang	3,592,932	HK$117.7m	0%	no data
0.12%	Beijing Baygen Technologies Ltd.	419,561	HK$13.7m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 12:00
End of Day Share Price	2024/12/24 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Biostar Pharmaceuticals Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Zhishun Siu	CCB International Securities Limited